Thrombospondin 2 Inhibits Microvascular Endothelial Cell Proliferation by a Caspase-independent Mechanism
The matricellular protein thrombospondin 2 (TSP2) regulates a
variety of cell–matrix interactions. A prominent feature of TSP2-null
mice is increased microvascular density, particularly in connective
tissues synthesized after injury. We investigated the cellular basis
for the regulation of angiogenesis by TSP2 in cultures of murine and
human fibroblasts and endothelial cells. Fibroblasts isolated from
murine and human dermis synthesize TSP2 mRNA and secrete significant
amounts of immunoreactive TSP2, whereas endothelial cells from mouse
lung and human dermis did not synthesize TSP2 mRNA or protein.
Recombinant mouse TSP2 inhibited growth of human microvascular
endothelial cells (HMVECs) mediated by basic fibroblast growth factor,
insulin-like growth factor-1, epidermal growth factor, and vascular
endothelial growth factor (VEGF). HMVECs exposed to TSP2 in the
presence of these growth factors had a decreased proportion of cells in
S and G2/M phases. HMVECs cultured with a combination of
basic fibroblast growth factor, insulin-like growth factor-1, and
epidermal growth factor displayed an increased proportion of nonviable
cells in the presence of TSP2, but the addition of VEGF blocked this
TSP2-mediated impairment of cell viability. TSP2-mediated inhibition of
DNA synthesis by HMVECs in the presence of VEGF was not affected by the
broad-spectrum caspase inhibitor zVAD-fmk. Similar findings were
obtained with TSP1. Taken together, these observations indicate that
either TSP2 or TSP1 can inhibit HMVEC proliferation by inhibition of
cell cycle progression and induction of cell death, but the mechanisms
responsible for TSP2-mediated inhibition of cell cycle progression are
independent from those leading to cell death.
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| bureauCode |
[
"009:25"
]
|
| contactPoint |
{
"fn": "NIH",
"@type": "vcard:Contact",
"hasEmail": "mailto:info@nih.gov"
}
|
| description | The matricellular protein thrombospondin 2 (TSP2) regulates a variety of cell–matrix interactions. A prominent feature of TSP2-null mice is increased microvascular density, particularly in connective tissues synthesized after injury. We investigated the cellular basis for the regulation of angiogenesis by TSP2 in cultures of murine and human fibroblasts and endothelial cells. Fibroblasts isolated from murine and human dermis synthesize TSP2 mRNA and secrete significant amounts of immunoreactive TSP2, whereas endothelial cells from mouse lung and human dermis did not synthesize TSP2 mRNA or protein. Recombinant mouse TSP2 inhibited growth of human microvascular endothelial cells (HMVECs) mediated by basic fibroblast growth factor, insulin-like growth factor-1, epidermal growth factor, and vascular endothelial growth factor (VEGF). HMVECs exposed to TSP2 in the presence of these growth factors had a decreased proportion of cells in S and G2/M phases. HMVECs cultured with a combination of basic fibroblast growth factor, insulin-like growth factor-1, and epidermal growth factor displayed an increased proportion of nonviable cells in the presence of TSP2, but the addition of VEGF blocked this TSP2-mediated impairment of cell viability. TSP2-mediated inhibition of DNA synthesis by HMVECs in the presence of VEGF was not affected by the broad-spectrum caspase inhibitor zVAD-fmk. Similar findings were obtained with TSP1. Taken together, these observations indicate that either TSP2 or TSP1 can inhibit HMVEC proliferation by inhibition of cell cycle progression and induction of cell death, but the mechanisms responsible for TSP2-mediated inhibition of cell cycle progression are independent from those leading to cell death. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Official Government Data Source",
"mediaType": "text/html",
"description": "Visit the original government dataset for complete information, documentation, and data access.",
"downloadURL": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC117612/"
}
]
|
| identifier | https://healthdata.gov/api/views/q3a7-8dmm |
| issued | 2025-07-14 |
| keyword |
[
"angiogenesis-inhibition",
"endothelial-cell-proliferation",
"microvascular-density",
"nih",
"thrombospondin-2"
]
|
| landingPage | https://healthdata.gov/d/q3a7-8dmm |
| modified | 2025-09-06 |
| programCode |
[
"009:033"
]
|
| publisher |
{
"name": "National Institutes of Health",
"@type": "org:Organization"
}
|
| theme |
[
"NIH"
]
|
| title | Thrombospondin 2 Inhibits Microvascular Endothelial Cell Proliferation by a Caspase-independent Mechanism |